This is a working overview of peptide bond, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2025-11-29 and is reviewed periodically as new material appears.
Whey protein hydrolysate appears in foods and supplements where rapid digestion, low viscosity, or reduced intact-protein content is desired. It is distinct from whey protein isolate and concentrate, which contain largely intact proteins, though hydrolysates can be made from either. In infant formula, extensively hydrolyzed whey is used in some specialty products, while partially hydrolyzed forms appear in other formulations. Human health effects depend on the specific peptide mixture and are not uniform across all hydrolysates.
Whey protein hydrolysate is a dairy ingredient produced when whey proteins are treated with proteolytic enzymes or, less commonly, acid or heat under controlled conditions. The treatment cleaves peptide bonds and yields shorter peptide chains than those found in intact whey protein. The starting material is usually sweet whey or acid whey from cheese manufacture, concentrated by membrane filtration before hydrolysis. The resulting ingredient retains many amino acids from the original protein but differs in molecular size, solubility, and taste profile.
Peptide size distribution is central to product characterization because biological and functional effects often depend on molecular weight. Size-exclusion chromatography, reversed-phase high-performance liquid chromatography, and capillary electrophoresis can separate peptides by size or hydrophobicity. Mass spectrometry provides sequence-level information and can detect marker peptides, though it is less common for routine lot release. For allergen control, enzyme-linked immunosorbent assays estimate residual intact protein or specific milk proteins, but results depend on antibody recognition and may not detect small peptides. No single method captures the full composition.
Stability and storage practices affect measured quality over time. Hydrolysate powders are hygroscopic and can absorb moisture, leading to caking, Maillard browning, and reduced solubility. Cool, dry storage in sealed containers limits these changes, while high humidity and warm temperatures accelerate them. Microbiological testing for total aerobic counts, yeasts, molds, and specified pathogens is typical for food ingredients. Regulatory status varies by country; in many jurisdictions hydrolyzed whey protein is regulated as a food ingredient rather than a drug, and claims about reduced allergenicity require specific substantiation.
| Property | Value | Notes |
|---|---|---|
| Common synonyms | Whey hydrolysate; hydrolyzed whey protein | Abbreviations such as WPH appear in ingredient lists |
| Appearance | Off-white to light cream powder | Color can vary with starting whey and drying method |
| Solubility class | Highly soluble in water | Short peptides often dissolve more readily than intact whey protein |
| Typical storage temperature | 15–25 °C | Cool, dry conditions limit moisture uptake and browning reactions |
| Typical analytical method | Size-exclusion chromatography | Used to estimate molecular weight distribution of peptides |
Whey protein hydrolysate appears in infant formula, sports nutrition, and clinical nutrition. In infant formula, extensively hydrolyzed products are used when a reduced allergenicity is desired, though not all hydrolysates are hypoallergenic. In sports products, the ingredient is marketed for rapid amino acid delivery, but the practical advantage over intact whey protein remains debated. Research often compares hydrolysate with isolate or concentrate for absorption kinetics, muscle protein synthesis, and gastrointestinal tolerance. Regulatory categories differ by country, and label terms such as partially hydrolyzed or extensively hydrolyzed are defined in some jurisdictions but not others.
Whey protein hydrolysate is a dairy ingredient made by treating whey protein with proteolytic enzymes. The starting material is whey, the liquid remaining after cheese or casein production, and its main proteins include beta-lactoglobulin, alpha-lactalbumin, and bovine serum albumin. Enzyme action breaks peptide bonds, producing shorter peptides and some free amino acids. The result is not a single uniform substance; composition depends on whey source, enzyme type, hydrolysis conditions, and downstream filtration. Hydrolysates are often described by average peptide length or degree of hydrolysis rather than by one fixed molecular weight.
Hydrolysate powders are hygroscopic and can absorb moisture during storage, which may promote caking, browning, and loss of solubility. Cool, dry conditions and sealed packaging slow these changes, while high humidity and warm temperatures accelerate Maillard reactions between peptides and residual sugars. Liquid hydrolysates are more perishable and often require refrigeration or preservatives. Shelf-life studies usually monitor moisture, color, solubility, free amino groups, and microbial load over time. Stability depends on residual lactose, water activity, packaging barrier properties, and the initial peptide profile.
Degree of hydrolysis is commonly estimated by titrating liberated carboxyl groups, measuring soluble nitrogen in trichloroacetic acid, or using o-phthaldialdehyde assays. Molecular weight distribution is often examined by size-exclusion chromatography, sodium dodecyl sulfate polyacrylamide gel electrophoresis, or mass spectrometry. These methods answer different questions: titration estimates bond cleavage, while chromatography describes peptide size ranges. Because no single reference method is universally applied, values reported by different laboratories may not be directly comparable. Method details such as calibration standards and sample preparation strongly influence results.
Composition tables often report protein content on a dry basis, ash, moisture, fat, and lactose. Because hydrolysis adds water to peptide bonds, the total mass yield can appear slightly higher than the original protein if residual salts and water are counted. Some products are further processed by ultrafiltration, spray drying, or decolorization, which alters mineral content and flavor. Product labels may distinguish partially hydrolyzed from extensively hydrolyzed whey, but these terms are not always defined by a single numerical threshold across regions.
Whey protein hydrolysate is a dairy ingredient made by treating whey protein with proteases that cleave peptide bonds. The starting material is typically whey protein concentrate or isolate, which contains beta-lactoglobulin, alpha-lactalbumin, and smaller amounts of bovine serum albumin and immunoglobulins. Hydrolysis shortens protein chains into peptides and free amino acids, changing solubility, viscosity, and flavor compared with intact whey protein. The extent of cleavage is commonly described by degree of hydrolysis, a percentage of broken peptide bonds relative to total bonds.
Enzyme choice influences the peptide size distribution and the resulting functional properties. Some proteases cut at specific amino acid residues, while others act more broadly, so two hydrolysates with the same degree of hydrolysis can differ in peptide sequences. Short peptides are generally more water-soluble and less likely to form gels under heat, although bitterness can increase when hydrophobic residues become exposed. The relationship between peptide length, taste, and bioactivity is an active area of study, and not all proposed effects are established in human trials.
Advanced peptide profiling uses liquid chromatography coupled with mass spectrometry to identify fragments and assess batch consistency. Amino acid analysis after acid hydrolysis quantifies the building blocks and can reveal deviations from expected composition. Residual enzyme activity may be monitored in products where active enzymes are undesirable. Allergen tests often use immunoassays for beta-lactoglobulin, but hydrolysis can reduce or alter epitope recognition, so negative results do not prove absence of allergenic potential. Physical tests include particle size, bulk density, and reconstitution behavior.
Regulatory and labeling frameworks vary by country. In the United States, whey protein hydrolysate may be regulated as a food ingredient or a dietary supplement ingredient depending on intended use. In the European Union, it falls under general food law, with additional rules for infant formula and foods for special medical purposes. A claim of hypoallergenicity is not established by hydrolysis alone and generally requires clinical evidence. Open questions remain about how degree of hydrolysis relates to bitterness, nitrogen absorption, and residual allergenicity across different products and processing methods.
Quality control for whey protein hydrolysate combines compositional and molecular tests. Protein content is measured by Kjeldahl or Dumas nitrogen determination. Moisture, ash, fat, and lactose are checked with standard food methods. The degree of hydrolysis is estimated by TNBS, OPA, or pH-stat procedures that quantify free amino groups or released protons. Molecular weight distribution is examined by size-exclusion chromatography or SDS-PAGE. These tests describe average peptide size rather than exact peptide sequences, and results depend on standards and calibration.
=== Books === Hocking, A. D.; Pitt, J. I.; Samson, Robert A.; Thrane, U., eds. (2006). Advances in Food Mycology. Advances in Experimental Medicine and Biology. Vol. 571. doi:10.1007/0-387-28391-9. ISBN 978-0-387-28385-2. McLauchlin, Jim; Little, Christine; Hobbs, Betty C. (2007). Hobbs' Food Poisoning and Food Hygiene. CRC Press. doi:10.1201/b13378. ISBN 978-1-4441-1374-7. Glass, Kathleen; Marshall, Kristin (2013). "Clostridium botulinum". Foodborne Infections and Intoxications. pp. 371–387. doi:10.1016/B978-0-12-416041-5.00027-5. ISBN 978-0-12-416041-5. Smith JL (2005). Fratamico PM, Bhunia AK, Smith JL (eds.). Foodborne Pathogens: Microbiology And Molecular Biology. Horizon Scientific Press. ISBN 978-1-904455-00-4.
Kazuaki Kiriya's action-thriller Last Knights was Freeman's first film of 2015, starring opposite Clive Owen. The plot centers on a band of warriors who seek to avenge the loss of their master at the hands of a corrupt minister. Reviews were largely underwhelming; Sara Stewart of New York Post called it "bloody bad", adding: "Once-proud box office names are its first casualties." Freeman next joined the cast of Ted 2, a comedy sequel to Ted, directed by Seth MacFarlane. The story follows the talking teddy bear Ted as he fights for civil rights in order to be recognized as a person. Freeman portrays Patrick Meighan, a highly respected civil rights attorney. A television series, Madam Secretary, also occupied Freeman's time. He played Chief Justice Frawley of the United States Supreme Court in a recurring role in the series. He and his producing partner Lori McCreary were executive producers. Freeman directed the first episode; McCreary remarked of his directing style, "What's riveting is that he can achieve a complete tonal change in performance with the least amount of direction ... Everybody behaves better when Morgan is there ... but he's very fun." At the end of 2015, Freeman played a U.S. senator in the thriller Momentum. Reprising his role as Allan Trumbull, Freeman appeared in London Has Fallen, the 2016 sequel to Olympus Has Fallen. The film follows a plot to assassinate the world leaders of the G7 as they attend the British Prime Minister's funeral in London, as well as Secret Service agent Mike Banning's efforts to protect U.S.
The emu has a prominent place in Australian Aboriginal mythology, including a creation myth of the Yuwaalaraay and other groups in New South Wales who say that the sun was made by throwing an emu's egg into the sky; the bird features in numerous aetiological stories told across a number of Aboriginal groups. One story from Western Australia holds that a man once annoyed a small bird, who responded by throwing a boomerang, severing the arms of the man and transforming him into a flightless emu. The Kurdaitcha man of Central Australia is said to wear sandals made of emu feathers to mask his footprints. Many Aboriginal language groups throughout Australia have a tradition that the dark dust lanes in the Milky Way represent a giant emu in the sky. Several of the Sydney rock engravings depict emus, and the birds are mimicked in Indigenous dances. Hunting emus, known as kari in the Kaurna language, features in the major Dreaming story of the Kaurna people of the Adelaide region about the ancestor hero Tjilbruke. The emu is popularly but unofficially considered as a faunal emblem – the national bird of Australia. It appears as a shield bearer on the Coat of arms of Australia with the red kangaroo, and as a part of the Arms also appears on the Australian 50-cent coin. It has featured on numerous Australian postage stamps, including a pre-federation New South Wales 100th Anniversary issue from 1888, which featured a 2 pence blue emu stamp, a 36-cent stamp released in 1986, and a $1.35 stamp released in 1994.
=== Other types === RIT 4385 is a newer strain derived from the Jeryl Lynn strain by Maurice Hilleman, Jeryl Lynn's father. Leningrad-3 strain was developed by Smrodintsev and Klyachko in guinea pig kidney cell culture and has been used since 1950 in former Soviet countries. This vaccine is routinely used in Russia. L-Zagreb strain used in Croatia and India was derived from the Leningrad-3 strain by further passaging. Urabe strain was introduced in Japan, and later licensed in Belgium, France and Italy. It has been associated with a higher incidence of meningitis (1/143 000 versus 1/227 000 for J-L), and abandoned in several countries. It was formulated as MMR in the UK. Rubini strain used mainly in Switzerland was attenuated by a higher number of passes through chicken embryos, and later proved to have low potency. It was introduced in 1985.
Sources: en.wikipedia.org
The prosecution's statistical evidence was strongly criticised, and comparisons were drawn with miscarriages of justice involving other nurses convicted of killing patients, including the cases of Lucia de Berk and Daniela Poggiali.
== Career == In early 1964, Sarkar presented his PhD research at the Federation of American Societies for Experimental Biology (FASEB) meeting in Chicago, where he was approached by Andrew Sass-Kortsak, a clinician specializing in Wilson's disease at Toronto's Hospital for Sick Children. Sass-Kortsak, then leading the hospital's Genetic Metabolic Program, sought a basic scientist to join his team and offered Sarkar a staff scientist position. This role included start-up funding and a dedicated laboratory in a newly constructed wing of the hospital. Shortly after, Sarkar received a cross-appointment to the University of Toronto's Department of Biochemistry. Sarkar began attending clinical Grand Rounds with Sass-Kortsak and visited Wilson's disease patients in hospital wards. His research shifted toward metal-related disorders, driven by his expertise in biophysical studies of metal-protein interactions and metal transport. Collaborating with Sass-Kortsak, Sarkar pioneered multidisciplinary research at SickKids, bridging basic science and clinical medicine to foster a collaborative institutional environment. In 1990, he was appointed head of the Division of Biochemistry Research at SickKids.
Rachel Jane Nickell (23 November 1968 – 15 July 1992) was a British woman who was stabbed to death on Wimbledon Common in southwest London on 15 July 1992. The initial police investigation of the crime resulted in the arrest in controversial circumstances of an innocent man, who was acquitted. Nickell was walking with her two-year-old son on Wimbledon Common when she was stabbed 49 times in the neck and torso and died at the scene. A lengthy police investigation to find the perpetrator followed, during which a suspect was wrongfully charged and later acquitted—before the case went cold. The detectives involved in arresting the innocent man had rejected, with "hostility", a suggestion from detectives investigating the November 1993 murders of single mother Samantha Bisset and her four-year-old daughter, Jazmine, as having been perpetrated by the same suspect due to a preponderance of similarities in the crimes. In 2006, a cold case investigation did identify Robert Napper – the man caught and convicted in 1995 for the Bisset murders – as Nickell's murderer. In 2008, Napper pleaded guilty to Nickell's manslaughter on the grounds of diminished responsibility. Napper, who was already detained at high-security Broadmoor Hospital in Berkshire for the Bisset murders, was ordered to be detained there indefinitely.
=== Psychosocial === Psychosocial interventions are used as an adjunct to pharmaceutical treatment and can be classified within behavior-, emotion-, cognition- or stimulation-oriented approaches. Behavioral interventions attempt to identify and reduce the antecedents and consequences of problem behaviors. This approach has not reported success in improving overall functioning, but can help to reduce some specific problem behaviors, such as incontinence. There is a lack of high quality data on the effectiveness of these techniques in other behavior problems such as wandering. Music therapy is effective in reducing behavioral and psychological symptoms. Emotion-oriented interventions include reminiscence therapy, validation therapy, supportive psychotherapy, sensory integration, also called snoezelen, and simulated presence therapy. A Cochrane review has found no evidence that this is effective. Reminiscence therapy (RT) involves the discussion of past experiences, individually or in groups, many times with the aid of photographs, household items, music and sound recordings, or other familiar items from the past. A 2018 review of the effectiveness of RT found that effects were inconsistent, small in size, and of doubtful clinical significance, and varied by setting. Simulated presence therapy (SPT) is based on attachment theories and involves playing a recording with the voices of the closest relatives of the person with AD. There is partial evidence indicating that SPT may reduce challenging behaviors.
Umami peptides are a family of small to medium length polypeptides found in a variety of savoury foods, which impart an umami taste. They are best known from Asian condiments and foods such as soy sauce, fish sauce, oyster sauce, and miso, but are also found in a diverse range of other foods including cheese, stewed or preserved meat products, and Bolete mushrooms. One of the best characterised umami peptides is beefy meaty peptide, originally isolated from beef soup, an eight amino acid peptide with the sequence Lys-Gly-Asp-Glu-Glu-Ser-Leu-Ala which is thought to interact with the T1R1/T1R3 taste receptor complex. There are dozens if not hundreds of umami peptides known, most of which have been little studied in isolation as they typically occur in complex mixtures, which can vary significantly between different foods, brands, and even different batches made the same way. Not all peptides isolated from such mixtures have umami flavour, with some closely related peptides tasting sweet, sour, salty, bitter or kokumi, and often a change in only a single amino acid can be enough to change the flavour entirely. However, the majority of peptides isolated from fermented foods or cooked or preserved meat products tend to have an umami flavour, with trace amounts of peptides with other flavours contributing to the overall flavour profile of the food.
Sources: en.wikipedia.org
It is made from whey, a byproduct of cheese or casein production, or from whey protein concentrate or isolate. Enzymes break the intact whey proteins into shorter peptides. The final composition depends on the starting whey and the hydrolysis conditions.
No. Whey protein isolate is a purified intact protein, while hydrolysate has been enzymatically cleaved into smaller peptides, and hydrolysate can be produced from isolate or concentrate. The two ingredients differ in molecular size, taste, and functional behavior.
Hydrolysis cleaves proteins but does not necessarily remove lactose, which is a sugar. It can reduce the size of allergenic proteins, yet residual peptides may still trigger reactions in sensitive individuals. Allergen status depends on the extent of hydrolysis and must be assessed for each product.
Hydrolysis extent is commonly estimated by quantifying free amino groups or soluble nitrogen after protein cleavage. The result is expressed as a percentage of cleaved peptide bonds. Different assays use different definitions and may not agree exactly.